Kim R M Blenman (Kim Blenman, Kim Rm Blenman)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 20

Top Topics

Neoadjuvant Chemotherapy

Top Venues

NPJ breast cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Cytometry. Part A : the journal of the International Society for Analytical Cytology

This page only lists publications with an associated author ORCID identifier.

Publications

Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, David L Rimm, Gabriel N Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R M Blenman
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial. NPJ breast cancer 9 (1) (2023)
Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, David L Rimm, Gabriel N Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R M Blenman
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial. NPJ breast cancer 9 (1) (2023)
Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, David L Rimm, Gabriel N Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R M Blenman
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial. NPJ breast cancer 9 (1) (2023)
Steven N Hart, Victor Garcia, Sarah N Dudgeon, Matthew G Hanna, Xiaoxian Li, Kim R M Blenman, Katherine Elfer, Amy Ly, Roberto Salgado, Joseph Saltz, Rajarsi R Gupta, Evangelos Hytopoulos, Denis Larsimont, Jochen Lennerz, Brandon D Gallas
Initial interactions with the FDA on developing a validation dataset as a medical device development tool. The Journal of pathology (2023)
Kristina A Fanucci, Yalai Bai, Vasiliki Pelekanou, Zeina A Nahleh, Saba Shafi, Sneha Burela, William E Barlow, Priyanka Sharma, Alastair M Thompson, Andrew K Godwin, David L Rimm, Gabriel N Hortobagyi, Yihan Liu, Leona Wang, Wei Wei, Lajos Pusztai, Kim R M Blenman
Image analysis-based tumor infiltrating lymphocytes measurement predicts breast cancer pathologic complete response in SWOG S0800 neoadjuvant chemotherapy trial. NPJ breast cancer 9 (1) (2023)
Julia Foldi, Adriana M Kahn, Andrea L M Silber, Tao Qing, Emily Reisenbichler, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Anees Chagpar, Tristen Park, Adam Blanchard, Kim R M Blenman, David L Rimm, Lajos Pusztai
Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Shawn M Hercules, Meena Alnajar, Chen Chen, Stefan M Mladjenovic, Bolade Ajarat Shipeolu, Olga Perkovic, Greg R Pond, Stefan D Baral, Kim R M Blenman, Juliet M Daniel
Triple-negative breast cancer prevalence in Africa: a systematic review and meta-analysis. BMJ open 12 (5) (2022)
Michał Marczyk, Vignesh Gunasekharan, David Casadevall, Tao Qing, Julia Foldi, Raghav Sehgal, Naing Lin Shan, Kim R M Blenman, Tess A O'Meara, Sheila Umlauf, Yulia V Surovtseva, Viswanathan Muthusamy, Jesse Rinehart, Rachel J Perry, Richard Kibbey, Christos Hatzis, Lajos Pusztai
Comprehensive Analysis of Metabolic Isozyme Targets in Cancer. Cancer research 82 (9) (2022)
Isobelle Wall, Victoire Boulat, Aekta Shah, Kim R M Blenman, Yin Wu, Elena Alberts, Dinis Pedro Calado, Roberto Salgado, Anita Grigoriadis
Leveraging the Dynamic Immune Environment Triad in Patients with Breast Cancer: Tumour, Lymph Node, and Peripheral Blood. Cancers 14 (18) (2022)
Tao Qing, Thomas Karn, Mariya Rozenblit, Julia Foldi, Michał Marczyk, Naing Lin Shan, Kim R M Blenman, Uwe Holtrich, Kevin M Kalinsky, Funda Meric-Bernstam, Lajos Pusztai
Molecular differences between younger versus older ER-positive and HER2-negative breast cancers. NPJ breast cancer 8 (1) (2022)
Kim R M Blenman, Michał Marczyk, Thomas Karn, Tao Qing, Xiaotong Li, Vignesh Gunasekharan, Vesal Yaghoobi, Yalai Bai, Eiman Y Ibrahim, Tristen Park, Andrea L M Silber, Denise M Wolf, Emily Reisenbichler, Carsten Denkert, Bruno Valentin Sinn, Mariya Rozenblit, Julia Foldi, David L Rimm, Sibylle Loibl, Lajos Pusztai
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Michal Marczyk, Tao Qing, Tess O'Meara, Vesal Yagahoobi, Vasiliki Pelekanou, Yalai Bai, Emily S Reisenbichler, Kimberly S Cole, Xiaotong Li, Vignesh Gunasekharan, Eiman Ibrahim, Kristina A Fanucci, Wei Wei, David L Rimm, Lajos Pusztai, Kim R M Blenman
Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer. NPJ breast cancer 8 (1) (2022)
Paula I Gonzalez Ericsson, Julia D Wulfkhule, Rosa I Gallagher, Xiaopeng Sun, Margaret L Axelrod, Quanhu Shen, Na Luo, Henry L Gómez, Violeta Sanchez, Melinda E Sanders, Lajos Pusztai, Emanuel Petricoin, Kim R M Blenman, Justin M Balko, null null
Tumor-Specific Major Histocompatibility-II Expression Predicts Benefit to Anti-PD-1/L1 Therapy in Patients With HER2-Negative Primary Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Mariya Rozenblit, Richard Huang, Natalie Danziger, Priti Hegde, Brian Alexander, Shakti Ramkissoon, Kim R M Blenman, Jeffrey S Ross, David L Rimm, Lajos Pusztai
Comparison of PD-L1 protein expression between primary tumors and metastatic lesions in triple negative breast cancers. Journal for immunotherapy of cancer 8 (2) (2021)
Kim R M Blenman, Josef Spidlen, David R Parks, Wayne Moore, Adam Treister, Robert Leif, Chris Bray, Michael Goldberg, null null, Ryan Brinkman
ISAC Probe Tag Dictionary: Standardized Nomenclature for Detection and Visualization Labels Used in Cytometry and Microscopy Imaging. Cytometry. Part A : the journal of the International Society for Analytical Cytology 99 (1) (2020)
Fahad Shabbir Ahmed, Patricia Gaule, John McGuire, Katir Patel, Kim R M Blenman, Lajos Pusztai, David L Rimm
PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Josef Spidlen, Wayne Moore, David Parks, Michael Goldberg, Kim R M Blenman, James S Cavenaugh, null null, Ryan R Brinkman
Data File Standard for Flow Cytometry, Version FCS 3.2. Cytometry. Part A : the journal of the International Society for Analytical Cytology 99 (1) (2020)
Pok Fai Wong, Wei Wei, James W Smithy, Balazs Acs, Maria I Toki, Kim R M Blenman, Daniel Zelterman, Harriet M Kluger, David L Rimm
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (8) (2019)
Kim R M Blenman, Jake Xiao Wang, Shawn Cowper, Marcus Bosenberg
Pathology of spontaneous and immunotherapy-induced tumor regression in a murine model of melanoma. Pigment cell & melanoma research 32 (3) (2019)
Kim R M Blenman, Marcus W Bosenberg
Immune Cell and Cell Cluster Phenotyping, Quantitation, and Visualization Using In Silico Multiplexed Images and Tissue Cytometry. Cytometry. Part A : the journal of the International Society for Analytical Cytology 95 (4) (2018)